Human PNPLA6 gene encodes Neuropathy Target Esterase protein (NTE). PNPLA6 gene mutations cause hereditary spastic paraplegia (SPG39 HSP), Gordon-Holmes syndrome, Boucher-Neuhäuser syndromes, Laurence-Moon syndrome, and Oliver-McFarlane syndrome. Mutations in the Drosophila NTE homolog swiss cheese (sws) cause early-onset, progressive behavioral defects and neurodegeneration characterized by vacuole formation. We investigated sws5 flies and show for the first time that this allele causes progressive vacuolar formation in the brain and progressive deterioration of negative geotaxis speed and endurance. We demonstrate that inducible, neuron-specific expression of full-length human wildtype NTE reduces vacuole formation and substantially rescues mobility. Indeed, neuron-specific expression of wildtype human NTE is capable of rescuing mobility defects after 10 days of adult life at 29°C, when significant degeneration has already occurred, and significantly extends longevity of mutants at 25°C. These results raise the exciting possibility that late induction of NTE function may reduce or ameliorate neurodegeneration in humans even after symptoms begin. In addition, these results highlight the utility of negative geotaxis endurance as a new assay for longitudinal tracking of degenerative phenotypes in Drosophila.
Citation: Sujkowski A, Rainier S, Fink JK, Wessells RJ (2015) Delayed Induction of Human NTE (PNPLA6) Rescues Neurodegeneration and Mobility Defects of Drosophila swiss cheese (sws) Mutants. PLoS ONE 10(12): e0145356. https://doi.org/10.1371/journal.pone.0145356
Editor: Efthimios M. C. Skoulakis, Alexander Fleming Biomedical Sciences Research Center, GREECE
Received: September 18, 2015; Accepted: December 2, 2015; Published: December 15, 2015
Copyright: © 2015 Sujkowski et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Data Availability: All relevant data are within the paper.
Funding: This investigation was supported by grants (to JKF) from the National Institutes of Health (R01 NS069700), Department of Veterans Affairs (Merit Review Award), the Spastic Paraplegia Foundation; the Geriatric Research, Education, and Clinical Center, Ann Arbor Veterans Affairs Medical Center, the Paul and Lois Katzman Family, and the generous contributions of private individuals and families and by support (to RJW) from the Wayne State Department of Physiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Mutations in human NTE (also known as patatin-like phospholipase domain containing protein 6, PNPLA6) cause diverse human neurologic disorders including hereditary spastic paraplegia (HSP), Gordon-Holmes syndrome, Boucher-Neuhäuser syndrome, Laurence-Moon syndrome, Oliver-McFarlane syndrome, and Leber’s congenital amarosis [1–3]. NTE has lysophospholipase B activity, converting lysophosphatidylcholine to glycerophosphocholine . Current animal models for PNPLA6-associated pathologies include the adult hen and mouse, but high cost and variable phenotypic presentation create significant limitations to these systems . Previous studies have established precedents for the use of mouse, hen, and recombinant human enzyme both in vitro and in vivo [5, 6]. Deletion of the mouse homolog is lethal , while brain-specific knockout mice show progressive neurodegenerative phenotypes .
The Drosophila homologue (sws) of human NTE appears to regulate cAMP-dependent protein kinase. [9, 10]. Null sws1 mutants reach adulthood but have a reduced lifespan and exhibit progressive neurodegeneration . Neurodegeneration in these animals involves neuronal and glial cell death in the brain, leading to the appearance of characteristic vacuoles  that can be rescued by continuous transgenic expression of either the fly, mouse or human homolog of NTE [12, 13].
sws5 is an EMS-generated point mutant  causing a glycine to arginine change in a highly-conserved residue near the reported PKA binding region . sws5 flies have shortened lifespans similar to or more severe than the null mutant . We examined the ability of wildtype human NTE to rescue neurodegeneration and mobility defects of sws5 mutants.
For the first time, we assessed whether post-developmental induction of a rescue construct could still ameliorate the neurodegenerative symptoms of a sws mutant. To provide temporal control of transgene induction, we used the RU-inducible gene switch system to induce neuron-specific expression of hNTE in adult sws mutant flies. For this, full-length hNTE was cloned into pUAST for use in the UAS/Gal4 expression system and a stable, mifepristone-inducible, pan-neuronal expression line (GS-elav-Gal4>UAS-hNTE) was crossed to sws5 mutant females. Male progeny receiving RU486 (RU+) after reaching adulthood expressed hNTE pan-neuronally in a hemizygous sws5 background and are referred to as “hNTE rescue” flies. Flies not receiving RU486 (RU-) are genetically identical siblings that received only vehicle, thus expressing the hemizygous mutant phenotype, but in a background identical to the rescue flies. These are used as a direct comparison for rescue, due to their identical genetic background with the rescue flies, distinct from the wild-type Berlin K background or the sws5 mutant in the Berlin K background.
It has been previously observed that neurodegeneration causes impaired mobility in Drosophila [14–16]. Furthermore, both induced locomotor activity and endurance have been shown to undergo a characteristic age-related decline in wild type flies [17–19]. In addition to standard neurodegeneration assays, we utilized an automated negative geotaxis machine, known as the Power Tower [19, 20], to monitor endurance as a novel assay for neurodegeneration in Drosophila.
hNTE Rescues sws5 Esterase Activity
Virgin females homozygous for the sws5 allele on the X chromosome were crossed to UAS-hNTE;elav GS males. Immediately following adult eclosion, transgene expression was induced by RU486 feeding and continued throughout adult life or until time of experimentation, whichever occurred first. Transgenic expression of hNTE in 10-day old sws5 hemizygous male fly heads was confirmed by Western blot. hNTE was completely absent in Berlin K, sws5 and control flies but highly expressed in hNTE rescue fly heads (Fig 1A). To confirm enzymatic activity of the transgene, we examined NTE-like esterase activity  in age-matched Berlin K, sws5, hNTE rescue and control groups. sws5 mutants and control transgenics had dramatically reduced NTE esterase activity, when compared to levels in the wild-type Berlin K line. Expression of hNTE completely restored NTE activity to the level of wild-type Berlin K flies (Fig 1B).
(A) hNTE protein is present in heads of adult hNTE rescue flies, but not controls or sws5 mutants. Loading control using anti-Tubulin is shown below. Representative image from 3 biological replicates. (n = 10 fly heads for each sample) (B) Esterase activity is reduced in sws5 mutants and control RU- flies in comparison to wild-type Berlin K (pairwise t-test, p = 0.006 and p = 0.0177, respectively). Flies expressing hNTE using elav-GAL4 increase esterase activity to the level of the wild type Berlin K (pairwise t-test, p = 0.9668). Data across groups were analyzed using two-way ANOVA with Bonferroni post-test and represent duplicate biological samples (n = 10, p≤0.0029, genotype effect, p<0.0001, RU effect, p = 0.0094, RU-by-genotype effect, p = 0.0038). (C) Age-matched sws5;hNTE;elav GS RU + flies display increased climbing vigor in comparison to flies without hNTE induction. Mifepristone (RU+) or vehicle (RU-) was fed to adult flies 3 days post-eclosion and maintained throughout life in order to induce transgene expression after development was complete. Photograph was taken 2 seconds after sharp rapping of vials onto a solid surface in order to induce negative geotaxis response.
hNTE Improves sws5 Negative Geotaxis
Negative geotaxis, a measure of Drosophila climbing behavior, declines with age and neurologic impairment [17, 22]. Adult sws1 mutant flies have shown early and progressive behavioral impairment . sws5 and RU- control flies also displayed severe mobility impairment in a stringent version of this assay measured over two seconds of climbing (Fig 1C). hNTE RU+ rescue flies had increased climbing performance compared to sws5 mutants and to genetically identical RU- controls when assessed daily in weeks 1 and 4 of adulthood, although rescue did not reach the level of wild type Berlin K flies (Fig 2A and 2B). sws5 cohorts were indistinguishable from RU- rescue flies (Fig 2A and 2B). All groups also showed significant decline with age from 1 to 4 weeks (Fig 2A and 2B).
(A) Average climbing ability is increased in hNTE rescue flies during week 1 of adult life in comparison to age-matched flies without hNTE expression (p≤0.0001), but not to the level of the wild-type Berlin K flies (p = 0.0001). Flies were assessed daily on days 4 through 8 at 29°C. Climbing performance was assessed on a minimum of 2 cohorts. Data were analyzed using two-way ANOVA with Bonferroni post-test. (n≥112, p≤0.0001, genotype effect, p<0.0001, RU effect, p = 0.0233, RU-by-genotype effect, p = .0003). (B)Average climbing performance assessed on days 25–29 (week 4) of adulthood is improved in hNTE rescue flies in comparison to age-matched flies without hNTE expression (p≤0.0001), but not fully rescued to wild-type levels (p≤0.0001). Climbing was assessed on a minimum of 2 separate biological cohorts. Data were analyzed using two-way ANOVA with Bonferroni post-test. (n≥84, p≤0.0001, genotype effect, p<0.0001, RU effect, p = .0043,RU-by-genotype effect, p<0.0001). Data from both timepoints (2A and 2B) were combined to assess effects across age, age effect, p<0.0001, RU effect, p<0.0001, interaction, p = 0.8656. Thus, there is an age-independent effect of RU on climbing. (C) Time to fatigue is increased in hNTE rescue flies compared to sws5 flies and uninduced controls. Endurance experiments are analyzed statistically by log-rank (n≥150 p≤0.0001). Flies were aged at 29°C and assessed for time-to-fatigue on the 10th day. (D) 24-day old control flies exhibit age-related decline in endurance relative to day 10. sws5 mutants and RU- control flies display marked reduction in time-to-fatigue- in comparison to Berlin K flies (log-rank, p≤0.0001). Time-to-fatigue is increased in hNTE rescue flies compared to sws5 and RU- controls (log rank, p≤0.0001), but not fully restored to wild-type (log rank with Pearson correlation, p = 0.0020). Endurance was assessed a minimum of 3 times to confirm reproducibility. n≥100 for all day-24 assessments.
hNTE Improves sws5 Endurance
We measured time to fatigue using the Power Tower, a machine that lifts and drops vials regularly to generate repetitive negative geotaxis stimuli . Fig 2C and 2D plots the time-to-fatigue of each vial as a time-to-event curve, referred to as a “runspan” . Vials are designated as fatigued when less than five flies out of 20 are climbing more than a centimeter up the tube after each drop. 10-day old Berlin K flies displayed typical endurance behavior, with the last vial of flies reaching fatigue after nearly 7 hours of continual climbing. In contrast, sws5 mutant flies showed a severely accelerated fatigue. No vial of 10-day-old sws5 mutant flies climbed >2 hours, a time-to-fatigue more typical of flies of five weeks of age or more . Endurance in RU- rescue flies was not significantly different from sws5 mutants. However, hNTE rescue cohorts displayed dramatically enhanced endurance. (Fig 2C). The improvement in time-to-fatigue in hNTE rescue flies was particularly impressive given that protein expression was not induced until adulthood.
To determine if rescue of endurance behavior persists with advancing age and neurodegeneration, time-to-fatigue was assessed in the same cohort of male flies on day 24 of adulthood. Both RU+ and RU- Berlin K flies showed an age-related decline in runspan. sws5 flies also exhibited a severe reduction in endurance performance, with all vials reaching fatigue in just over an hour. Performance in RU- uninduced controls was indistinguishable from sws5 mutants. Importantly, hNTE rescue flies fatigued at almost the same time as age-matched wild-types (Fig 2D), indicating that continued transgene expression provides long-term protection against accelerated neurodegeneration.
Vacuolization of sws5 Brains Is Reduced By hNTE
Widespread vacuolization caused by neuronal cell death has been previously observed in sws mutant fly brains [11, 23]. We evaluated the degree to which hNTE expression affected sws histopathology in age-matched cohorts 48 hours after endurance assessment. Wild-type Berlin K flies displayed normal brain morphology (Fig 3A). Brains from sws5 flies displayed vacuoles throughout, as well as darkly stained areas characteristic of cell death and apoptosis (Fig 3B), as previously observed in brains from sws1 and sws4 flies .
Representative 40X images of 500 nm transverse sections (approximately 75μm caudal to first appearance of tissue) of Drosophila right hemisphere from 10-day old flies. Berlin K RU+/RU- and sws5 RU+/RU- were morphologically identical, so a single image is presented for clarity. (A) Background control flies have no vacuoles present. (B) sws5 and RU- control flies exhibit characteristic vacuolization. (C, D) sws5 flies expressing adult-specific hNTE have reduced percent vacuolization when compared to mutants (as quantified in E). (E) Quantification of percent vacuolization phenotype from sectioned Drosophila brains. Berlin K RU+/RU- and sws5 RU+/RU- cohorts did not display statistically significant differences in area of brain occupied by vacuoles and are pooled. Data represent total area of vacuoles divided by total sample area. Although overall RU effect is not significant, sws5 flies expressing pan-neuronal hNTE display significantly less vacuolization area in comparison to uninduced mutants (pairwise t-test, p≤0.0001) and uninduced controls (pairwise t-test, p≤0.0001) (two-way ANOVA with Bonferroni post-test, p≤0.0001, genotype effect, p<0.0001, RU effect, p = 0.8707, RU-by-genotype effect, p = 0.9324). n≥23 flies of each genotype.
RU- control flies displayed similar histology to sws5 mutants. Multiple vacuoles of varying sizes were visible in all brain sections, and dark toluidine blue segments were apparent (Fig 3C). Although control and hNTE rescue flies had a similar number of vacuoles, measurement of average vacuole area per brain revealed less brain area lost to vacuolization (Fig 3D and 3E). Therefore, adult-specific neural hNTE expression appeared to reduce the rate of vacuole expansion without decreasing vacuole number.
Delayed hNTE Expression Improves sws5 Motor Function and Histopathology
As adult-induced rescue was able to improve mobility and reduce histopathology, we examined the effect of hNTE expression even later in adult life, after significant degeneration had occurred. We performed 4 consecutive endurance tests in conjunction with delayed induction of gene expression. Mutant, rescue, and control cohorts were allowed to eclose and mature at 29°C for one week. From day 7, all cohorts were provided either food containing RU for continuous hNTE induction (RU+) or food containing vehicle only (RU-).
The first endurance assessment was performed three days after eclosion. Control Berlin K flies climbed continuously for a maximum time of 400 minutes. Both sws5 mutant flies and RU- rescue flies showed severely impaired endurance in comparison to Berlin K (Fig 4A). On day five, time-to-fatigue was similar to day three, with wild-type flies displaying much better endurance than sws deficient flies (Fig 4B). Subtle shifts in maximal time to fatigue were observed in the 3 cohorts at this timepoint for reasons that are not clear. Importantly, the relative difference between control Berlin K and sws5 deficient cohorts remained highly significant. Immediately after assessment on day five, flies were given either inducing RU486 or RU- vehicle, then reassessed two days later.
Endurance tolerance was assessed before (A, B) and after (C, D) mifepristone (RU486) application and induction of hNTE expression. (A) Berlin K flies exhibit wild-type endurance on day 3 of adulthood, while both sws5 mutant and sws5;hNTE;elav GS show a marked reduction in time-to-fatigue (n = 200 for all groups, log-rank, p<0.0001). (B) 48 hours later sws5 mutant and sws5;hNTE;elav GS cohorts continue to exhibit much lower endurance than Berlin K controls (n = 200 for all groups, long-rank, p<0.0001). At the end of the day-5-test, cohorts are divided in half and split into induced (RU+) and control (RU-) groups. (C) The same flies from (A) and (B) are tested for endurance 48 hours after mifepristone induction. Berlin K flies begin to decline in performance compared to day 5, independent of RU486 feeding (log rank, p≤0.0001 for RU+ and RU-). sws5 mutant and sws5;hNTE;elav GS cohorts show reduced endurance relative to Berlin K whether RU486-fed or not (n = 100 for all groups, long-rank, p<0.0001). (D) On day 10, after 120 hours RU486 induction, hNTE rescue flies’ (sws5;hNTE;elav GS RU+) time-to-fatigue is fully rescued to wild-type Berlin K endurance capacity (log rank, p = 0.9436). sws5 mutant and RU- control groups remain deficient in time-to-fatigue (log rank, p<0.0001). n = 100 for all cohorts.
After seven days at 29°C, Berlin K flies began to exhibit a decline in endurance compared to day 5, as analyzed by log-rank (p≤0.0001) (Fig 4C). sws5, control, and hNTE rescue cohorts all retain much lower time-to-fatigue than wild-type groups, and are not significantly different from one another (Fig 4C). Thus, hNTE rescue expression between days five and seven had little effect. sws5 flies do not decline in endurance during the first week of age as much as wild-type flies do (p = 0.4072 and p = 0.2550 for ages 3–5, and 5–7 days), perhaps because their performance is so low already.
Time-to-fatigue on day ten was noticeably different from previous assessments. By this time, experimental flies had been exposed to the drug for 120 hours, allowing increased time for hNTE expression. Both sws5 and RU- rescue flies continued to exhibit progressive decline in time-to-fatigue between day 7 and day 10 (log rank, p≤ 0.0001 for both) (Fig 4D). Surprisingly, hNTE rescue flies show enhanced endurance on day 10, with a time-to-fatigue fully rescued to the level of age-matched Berlin K flies (p = 0.9436) (Fig 4D). This result indicates that progressive decline in endurance of sws5 mutants was fully reversed by 120 hours of hNTE expression. The effect of age on endurance across groups was highly significant for this experiment (chi-square 144.4, p<0.0001) and the RU treatment-by-age effect was also highly significant (chi-square 255.6, p<0.0001).
Following assessment of time-to-fatigue at 10 days, brains from flies of each cohort were sectioned within 48 hours in order to directly correlate brain histology with endurance. 10-day old Berlin K flies aged at 29°C showed wild-type morphology, as in Fig 3A. No vacuoles were present in any sample (Fig 5A). In our hands, brains of flies containing the sws5 mutation appeared smaller than wild-type cohorts relative to the head capsule regardless of hNTE expression. Therefore, the plane of sectioning was measured in reference to the exterior of the head capsule for purposes of comparison (see Methods). sws5 flies displayed vacuoles throughout all brain sections, many being very large in area (Fig 5B). Vacuoles in vehicle-fed rescue flies were also numerous and large in size (Fig 5C). Consistent with their improved fatigue tolerance, delayed hNTE rescue cohorts exhibited a lesser area of brain occupied by vacuoles than either sws5 mutants or RU- rescue samples, although still more than wild-type controls (Fig 5D and 5E). This result further supports the idea that neurodegeneration as a result of reduced NTE activity is responsive to treatment even after substantial deterioration has occurred.
Representative 40X images of 500 nm horizontal sections of Drosophila brains from 10-day old flies with induced hNTE expression delayed until after one week of adulthood. Plane of sectioning, pooling of statistically and morphologically identical samples, and analyses are same as Fig 3. (A-C) Berlin K, sws5 and control fly brains show similar histology to previously described cohorts. (D) Delayed hNTE expression rescues percent vacuolization to the same degree as expression throughout adulthood (p≤0.4405). (E) Quantification of percent vacuolization phenotype. Two-way ANOVA with Bonferroni post-test, pairwise p values as indicated in panel, overall genotype effect, p<0.0001, overall RU effect, p = 0.2236, overall genotype-by-RU effect, p = 0.0223. n≥23 flies of each genotype.
hNTE Improves sws5 Survival
Various sws mutants, including sws5, have been previously shown to exhibit a reduction in lifespan . Because adult-specific neural expression was sufficient to improve climbing ability, mobility, and brain histology, we examined its effect on survival in sws5 flies. In our hands, sws5 flies lived longer at 29°C than previously observed, with a maximum lifespan around 40 days (Fig 6A). Both median and maximal sws5 lifespan was reduced, however, in comparison to Berlin K, RU- controls and hNTE RU+ rescue flies (Fig 6A). Since survival differences at 29°C were modest, we decided to repeat the experiment at a lower temperature, where wild type longevity is higher.
(A) sws5 mutants have reduced lifespan at 29°C in comparison to both Berlin K RU+/RU- and sws5;hNTE;elav GS (RU+/RU-) flies (n≥248, log rank, p<0.0001). sws5;hNTE;elav GS RU- (RU- control) flies have slightly reduced lifespan relative to Berlin K RU+/RU- and sws5;hNTE;elav GS RU+ (hNTE rescue) flies (n≥248, log rank, p = 0.006) but are longer lived than sws5 RU+/RU- flies (n≥248, log rank, p<0.0001). (B) sws5 mutants (RU+/RU-) and RU- control flies have reduced lifespan at 25°C in comparison to Berlin K (RU+/RU-) and hNTE rescue flies (n≥243, log rank, p<0.0001). Survival of hNTE rescue flies is nearly fully rescued to wild-type Berlin K lifespan at 25°C but is still statistically significant (n≥247, log rank, p<0.0001.
At 25°C sws5 flies exposed to either RU486 or vehicle, and RU- control groups displayed marked reductions in both median and maximal lifespan relative to Berlin K control groups (Fig 6B). hNTE RU+ rescue flies exhibit a substantial rescue of survival at 25°C, with improvements in both median and maximum lifespan relative to mutant and RU- control groups (Fig 6B).
Neurodegenerative diseases are almost always diagnosed well after onset of symptoms [24, 25]. Reducing impairment after the development of disease is thus an important therapeutic goal. Significant neuronal cell death and vacuolization in sws5 mutants is observed within the first ten days of life, while mobility impairments are apparent by day 3 of age.
Whereas previous studies also observed reduced vacuole formation in sws1 flies overexpressing Drosophila, mouse, or human PLNPA6 [12, 13], here we correlate reduced vacuole formation with longitudinal measures of mobility performance using a recently developed protocol for measuring Drosophila endurance. Measuring endurance with an automated system for inducing negative geotaxis behavior offers a non-invasive assessment of both coordination and strength, suitable for longitudinal assessment of performance decline. This system effectively measures performance decline as a result of either muscle-specific interventions (e.g.  or neuron-specific interventions (Sujkowski and Wessells, unpublished observation). This system can be useful for future assessments of degenerative disease models or as an assessment of functional aging.
Because hNTE expression was not induced in mutants until after development was complete, some developmental mobility defects could have persisted in adult hNTE rescue flies. However, hNTE rescue flies exhibited consistently faster climbing speed and higher endurance in comparison to both sws5 mutants and transgenic controls. Furthermore, induction of rescue even after substantial decline has taken place in adults can not only slow decline, but actually reverse the decline in endurance of a longitudinally measured cohort.
Although we demonstrate reversal of mobility decline by late rescue, we do not find a reversal of vacuole formation. Rather we find that rescue strongly decreases the percent vacuolization at later time points. This result is consistent with the idea that rescue slows the expansion of existing vacuoles.
Taken together, these observations imply that protection of mobility may not absolutely require reversal of vacuole formation. Blocking the formation of additional vacuoles, or blocking the expansion of existing vacuoles may be sufficient to allow some degree of functional recovery. These results support the idea that induction of NTE activity may be therapeutically valuable even after substantial degeneration has occurred. Extending these studies to vertebrate models of NTE mutation will be critical.
Materials and Methods
Creating transgenic Drosophila lines
hNTE cDNA was generously provided by Paul Glynn. The cDNA sequence was ligated into the p[PUAST] expression vector for use in the UAS/Gal4 ectopic expression system. Transgenic flies were created by injecting p[PUAST]-hNTE constructs into w1118 Drosophila embryos. A stable line containing both UAS-hNTE and a drug-inducible GS-elav-Gal4 was generated using standard genetic cross schemes.
Fly Stocks and Maintenance
All parental lines were reared at 25°C, 50% humidity with a 12 hour light-dark cycle and provided with a standard 10% yeast/10% sucrose diet. w1118 and Berlin K were obtained from the Bloomington Drosophila Stock Center; sws5 flies (generated in a wild-type Berlin K background ) were generously provided by Dr. Doris Kretzschmar. GS-elav-Gal4 was generously provided by Scott Pletcher (University of Michigan), then mobilized to the third chromosome and backcrossed for 10 generations into w1118. Resulting rescue flies were subsequently in a mixed w1118-Berlin K background. Possible genetic background effects were further controlled by using GS-elav-Gal4 and defining RU- flies of the same mixed background as the negative control.
Experimental F1 male progeny were reared and aged as follows: 20 sws5 virgin females and 5 UAS-hNTE;elav GS males were mated in 300 mL bottles with 50 mL standard 10% sucrose/10% yeast diet at 25°C, whereupon eggs were allowed to undergo and complete development. Adult progeny were age-matched by collecting within 2 hours of eclosion over a 48 hour time period. At least 400 adult males were collected for each genotype and immediately transferred into narrow polypropylene vials containing 5mL standard 10% yeast/ 10% sucrose food medium. Populations were split into “induced” and “control” flies and transferred to 5mL standard food medium containing either 100 μM mifepristone or 70% ethanol vehicle, respectively. Experimental and control flies were then housed at 29°C and allowed to age on either RU486 or vehicle until experimentation.
For delayed-induction experiments, synchronous male progeny were allowed to complete development at 25°C as above, and then aged for an additional 72 hours at 29°C on standard 10% yeast/10% sucrose media prior to being split into “induced” and “control” groups. Aged flies were then transferred to 5mL vials containing the addition of mifepristone or vehicle. All experimental groups were transferred to appropriate fresh food every second day. Survival analyses were performed concurrently on days of transfer.
50 flies of each genotype were decapitated and separated. Triplicate biological samples of 10 isolated heads were homogenized and equal amounts of protein were loaded per lane. Gels and blots were performed as previously described . Mouse monoclonal anti-hNTE (generously provided by Dr. Rudy Richardson) was used at 1:500. Following hNTE detection, blots were stripped and re-probed with mouse anti-tubulin (mouse monoclonal T5168, 1:10,000; Sigma-Aldrich) as loading control. Anti-mouse secondary antibody (Jackson Immunoresearch) was diluted to 1:5000.
NTE was inhibited by preincubation with organophosphorus (OP) compounds as in Makhaeva et al. . Homogenates from isolated Drosophila heads were diluted in 50 mM Tris-HCl, 1 mM EDTA, pH 8.0 at 37°C. NTE activity was defined as the Phenyl valerate (PV) hydrolase activity inhibited by preincubation for 20 min with 40 μM paraoxon (PO) but not abolished by preincubation for 20 min with 40 μM PO plus 50 μM mipafox (MIP) [5, 28]. 50 decapitated heads were assessed for each genotype, and duplicate biological samples were tested. Total protein from isolated heads was assessed in parallel using the Pierce BCA Protein Assay Kit (Rockford, IL).
Negative Geotaxis Behavior
Flies were transferred into fresh polypropylene vials in a RING apparatus as in [17, 19] and allowed to equilibrate. Negative geotaxis was induced by rapping the fly vials 4 times in rapid succession. Fly positions were captured as digital images 2 seconds after eliciting climbing behavior. ImageJ analysis software  computed the distance climbed by each fly (NIH, Bethesda, MD). Distances were converted into quadrants using Microsoft Excel. The performance of at least 100 flies (five to six vials of 20 flies each) was calculated as the average of four consecutive trials to determine the average distance climbed per vial. Data were collected daily for 5 days in weeks 1 and 4. Daily measurements during each week were averaged across the five days and presented as average weekly climbing speed. Between RING assessments, flies were returned to appropriate media and returned to 29°C until the following day. Weekly data were analyzed using two-way ANOVA with Bonferroni post-test to compare significantly different values. Negative geotaxis experiments were repeated on a minimum of 2 biological cohorts.
Similar to negative geotaxis behavior, endurance in Drosophila shows a characteristic age-related decline. [18, 19]. Flies are divided into 8 groups of 20 individuals and placed on an automated negative geotaxis inducing machine [19, 20]. When fewer than 5 flies in a vial are able to climb above 1 cm, the vial is scored as “fatigued” and removed from the apparatus.
After 10 days of aging at 29°C, 5 to10 vials of flies from each genotype were assessed for time-to-fatigue using the endurance assay described by Tinkerhess et al. . Each data point represents the time at which a vial of flies was removed and scored as “fatigued”. Data were presented as survival curves and analyzed by log rank. At 24 days of aging at 29°C, approximately 20% of the flies from each cohort had died, but survival proportions for all groups was not significantly different when analyzed by log rank. For delayed-induction experiments, 10 vials of each cohort were assessed on normal 10% sucrose/10% yeast diet at days 3 and 5. At the conclusion of the day-5 endurance test, the same 10 vials were split into “induced” and “control” groups and placed on RU486 food, or normal diet containing an equal amount of 70% ethanol vehicle, respectively. Thus, 5 vials of 20 flies were assessed for fatigue tolerance in each cohort. Runspan graphs containing less than the previously-stated number of data points indicate that more than one vial reached fatigue at the same time. All endurance experiments were repeated a minimum of 3 times to confirm reproducibility.
Adult Brain Histology
Live flies were fixed in 4% paraformaldehyde, 2.5% glutaraldehyde as previously described . Transverse sections of approximate midbrain were obtained by taking 150 500 nm slices from the first appearance of tissue and mounting the slice at the final plane. Light microscopy was performed on 500 nM-thick horizontal sections stained with 1% toluidine blue and 1% borax in water. Bright field microscopy was performed using an Olympus BX-51 upright light microscope outfitted with an Olympus DP-70 camera and software. Both central brain and optic lobe were analyzed for appearance of vacuoles by both number and % area using ImageJ (Bethesda, MD) software. Data were exported to Microsoft Excel for quantification. Vacuolization of brain tissue was not found to be significantly different between brain regions analyzed (optic lobe and central brain) and were subsequently pooled. Vacuolar area was not found to be significantly different between Berlin K RU- and RU+ nor between sws5 RU- and RU+ and were similarly pooled for analysis.
The authors wish to acknowledge the support and many helpful discussions of Rudy Richardson, the generous technical guidance of Sokol Todi for enzymatic assays, and helpful suggestions from anonymous reviewers.
Conceived and designed the experiments: AS SR JKF RJW. Performed the experiments: AS. Analyzed the data: AS JKF RJW. Contributed reagents/materials/analysis tools: SR JKF. Wrote the paper: AS JKF RJW.
- 1. Synofzik M, Gonzalez MA, Lourenco CM, Coutelier M, Haack TB, Rebelo A, et al. PNPLA6 mutations cause Boucher-Neuhauser and Gordon Holmes syndromes as part of a broad neurodegenerative spectrum. Brain. 2014;137(Pt 1):69–77. pmid:24355708; PubMed Central PMCID: PMC3891450.
- 2. Kmoch S, Majewski J, Ramamurthy V, Cao S, Fahiminiya S, Ren H, et al. Mutations in PNPLA6 are linked to photoreceptor degeneration and various forms of childhood blindness. Nat Commun. 2015;6:5614. pmid:25574898; PubMed Central PMCID: PMC4356490.
- 3. Hufnagel RB, Arno G, Hein ND, Hersheson J, Prasad M, Anderson Y, et al. Neuropathy target esterase impairments cause Oliver-McFarlane and Laurence-Moon syndromes. J Med Genet. 2015;52(2):85–94. pmid:25480986.
- 4. Zaccheo O, Dinsdale D, Meacock PA, Glynn P. Neuropathy target esterase and its yeast homologue degrade phosphatidylcholine to glycerophosphocholine in living cells. J Biol Chem. 2004;279(23):24024–33. pmid:15044461.
- 5. Makhaeva GF, Rudakova EV, Hein ND, Serebryakova OG, Kovaleva NV, Boltneva NP, et al. Further studies toward a mouse model for biochemical assessment of neuropathic potential of organophosphorus compounds. J Appl Toxicol. 2014;34(12):1426–35. pmid:24395470; PubMed Central PMCID: PMC4085144.
- 6. Makhaeva GF, Aksinenko AY, Sokolov VB, Baskin II, Palyulin VA, Zefirov NS, et al. Kinetics and mechanism of inhibition of serine esterases by fluorinated aminophosphonates. Chem Biol Interact. 2010;187(1–3):177–84. pmid:20035729.
- 7. Moser M, Li Y, Vaupel K, Kretzschmar D, Kluge R, Glynn P, et al. Placental failure and impaired vasculogenesis result in embryonic lethality for neuropathy target esterase-deficient mice. Mol Cell Biol. 2004;24(4):1667–79. pmid:14749382; PubMed Central PMCID: PMC344166.
- 8. Akassoglou K, Malester B, Xu J, Tessarollo L, Rosenbluth J, Chao MV. Brain-specific deletion of neuropathy target esterase/swisscheese results in neurodegeneration. Proc Natl Acad Sci U S A. 2004;101(14):5075–80. pmid:15051870; PubMed Central PMCID: PMC387376.
- 9. Bettencourt da Cruz A, Wentzell J, Kretzschmar D. Swiss Cheese, a protein involved in progressive neurodegeneration, acts as a noncanonical regulatory subunit for PKA-C3. J Neurosci. 2008;28(43):10885–92. pmid:18945896; PubMed Central PMCID: PMC2723165.
- 10. Wentzell JS, Cassar M, Kretzschmar D. Organophosphate-induced changes in the PKA regulatory function of Swiss Cheese/NTE lead to behavioral deficits and neurodegeneration. PLoS One. 2014;9(2):e87526. pmid:24558370; PubMed Central PMCID: PMC3928115.
- 11. Kretzschmar D, Hasan G, Sharma S, Heisenberg M, Benzer S. The swiss cheese mutant causes glial hyperwrapping and brain degeneration in Drosophila. J Neurosci. 1997;17(19):7425–32. pmid:9295388.
- 12. Muhlig-Versen M, da Cruz AB, Tschape JA, Moser M, Buttner R, Athenstaedt K, et al. Loss of Swiss cheese/neuropathy target esterase activity causes disruption of phosphatidylcholine homeostasis and neuronal and glial death in adult Drosophila. J Neurosci. 2005;25(11):2865–73. pmid:15772346; PubMed Central PMCID: PMC1182176.
- 13. Topaloglu AK, Lomniczi A, Kretzschmar D, Dissen GA, Kotan LD, McArdle CA, et al. Loss-of-function mutations in PNPLA6 encoding neuropathy target esterase underlie pubertal failure and neurological deficits in Gordon Holmes syndrome. J Clin Endocrinol Metab. 2014;99(10):E2067–75. pmid:25033069.
- 14. Kim M, Park HL, Park HW, Ro SH, Nam SG, Reed JM, et al. Drosophila Fip200 is an essential regulator of autophagy that attenuates both growth and aging. Autophagy. 2013;9(8):1201–13. pmid:23819996; PubMed Central PMCID: PMCPMC3748192.
- 15. Petersen AJ, Rimkus SA, Wassarman DA. ATM kinase inhibition in glial cells activates the innate immune response and causes neurodegeneration in Drosophila. Proc Natl Acad Sci U S A. 2012;109(11):E656–64. pmid:22355133; PubMed Central PMCID: PMCPMC3306708.
- 16. Zhang S, Feany MB, Saraswati S, Littleton JT, Perrimon N. Inactivation of Drosophila Huntingtin affects long-term adult functioning and the pathogenesis of a Huntington's disease model. Dis Model Mech. 2009;2(5–6):247–66. pmid:19380309; PubMed Central PMCID: PMCPMC2675792.
- 17. Gargano JW, Martin I, Bhandari P, Grotewiel MS. Rapid iterative negative geotaxis (RING): a new method for assessing age-related locomotor decline in Drosophila. Exp Gerontol. 2005;40(5):386–95. pmid:15919590.
- 18. Bazzell B, Ginzberg S, Healy L, Wessells RJ. Dietary composition regulates Drosophila mobility and cardiac physiology. J Exp Biol. 2013;216(Pt 5):859–68. pmid:23155082; PubMed Central PMCID: PMC3571989.
- 19. Tinkerhess MJ, Ginzberg S, Piazza N, Wessells RJ. Endurance training protocol and longitudinal performance assays for Drosophila melanogaster. J Vis Exp. 2012; (61). pmid:22472601; PubMed Central PMCID: PMC3460591.
- 20. Piazza N, Gosangi B, Devilla S, Arking R, Wessells R. Exercise-training in young Drosophila melanogaster reduces age-related decline in mobility and cardiac performance. PLoS One. 2009;4(6):e5886. pmid:19517023; PubMed Central PMCID: PMC2691613.
- 21. Vilanova E, Barril J, Carrera V. Biochemical properties and possible toxicological significance of various forms of NTE. Chem Biol Interact. 1993;87(1–3):369–81. pmid:8343994.
- 22. Barone MC, Bohmann D. Assessing neurodegenerative phenotypes in Drosophila dopaminergic neurons by climbing assays and whole brain immunostaining. J Vis Exp. 2013; (74):e50339. pmid:23644755; PubMed Central PMCID: PMC3667574.
- 23. Kretzschmar D. Neurodegenerative mutants in Drosophila: a means to identify genes and mechanisms involved in human diseases? Invert Neurosci. 2005;5(3–4):97–109. pmid:16187075.
- 24. Fink JK. Hereditary spastic paraplegia. Neurol Clin. 2002;20(3):711–26. pmid:12432827.
- 25. Salinas S, Proukakis C, Crosby A, Warner TT. Hereditary spastic paraplegia: clinical features and pathogenetic mechanisms. Lancet Neurol. 2008;7(12):1127–38. pmid:19007737.
- 26. Tinkerhess MJ, Healy L, Morgan M, Sujkowski A, Matthys E, Zheng L, et al. The Drosophila PGC-1alpha homolog spargel modulates the physiological effects of endurance exercise. PLoS One. 2012;7(2):e31633. pmid:22348115; PubMed Central PMCID: PMC3278454.
- 27. Tsou WL, Ouyang M, Hosking RR, Sutton JR, Blount JR, Burr AA, et al. The deubiquitinase ataxin-3 requires Rad23 and DnaJ-1 for its neuroprotective role in Drosophila melanogaster. Neurobiol Dis. 2015;82:12–21. pmid:26007638.
- 28. Hein ND, Rainier SR, Richardson RJ, Fink JK. Motor neuron disease due to neuropathy target esterase mutation: enzyme analysis of fibroblasts from human subjects yields insights into pathogenesis. Toxicol Lett. 2010;199(1):1–5. pmid:20603202; PubMed Central PMCID: PMC4310456.
- 29. Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 2012;9(7):671–5. pmid:22930834.